Health In Tech Inc. (HIT)
NASDAQ (CM) NASDAQ (CM) Primary 
Health In Tech Q1 Earnings Call Highlights
Health In Tech NASDAQ: HIT reported first-quarter 2026 revenue growth and a wider loss as management said the company is intentionally increasing investment in sales distribution, carrier relationships and technology development to pursue a larger share of the self-funded health insurance market.
Health In Tech, Inc. (HIT) Q4 2025 Earnings Call Transcript
Health In Tech, Inc. (HIT) Q4 2025 Earnings Call Transcript
Health In Tech, Inc. (HIT) Q3 2025 Earnings Call Transcript
Health In Tech, Inc. ( HIT ) Q3 2025 Earnings Call November 10, 2025 5:00 PM EST Company Participants Lori Babcock - Chief of Staff Tim Johnson - Founder, CEO & Chairman Dustin Plantholt - Chief Artificial Intelligence & Marketing Officer Julia Qian - CFO & Director Conference Call Participants Marla Marin - Zacks Small-Cap Research James Lieberman Allen Klee - Maxim Group LLC, Research Division Presentation Operator Good day, ladies and gentlemen. Thank you for standing by, and welcome to the Health In Tech Third Quarter of 2025 Earnings Conference Call.
Health In Tech, Inc. (HIT) Shareholder/Analyst Call Prepared Remarks Transcript
Health In Tech, Inc. (NASDAQ:HIT ) Shareholder/Analyst Call October 3, 2025 10:00 AM EDT Company Participants Tim Johnson - Founder, CEO & Chairman Lori Babcock - Chief of Staff Conference Call Participants Karen Smith Presentation Operator Good morning, and welcome. The time is now 10:07 a.m.
Health In Tech: Validating Its Growth With Solid Results
Health In Tech is delivering explosive revenue and EBITDA growth, validating its consumer-centric, AI-driven Insurtech platform and business model. The company's aggressive expansion and robust distribution network position it for continued outperformance in the high-growth U.S. digital health insurance market. Valuation is justified by rapid revenue growth, improving profitability, and a premium multiple relative to China-based peers, with a 2026 price target of $5.70.
Health In Tech, Inc. (HIT) Q2 2025 Earnings Call Transcript
Health In Tech, Inc. (NASDAQ:HIT ) Q2 2025 Earnings Conference Call July 21, 2025 5:00 PM ET Company Participants Lori Babcock - Chief of Staff Tim Johnson - Chief Executive Officer and Director Dustin Plantholt - Chief Growth Officer Julia Qian - Chief Financial Officer and Director Conference Call Participants Alan Klee - Maxim Group M Marin - Zacks Operator Good day, ladies and gentlemen. Thank you for standing by, and welcome to the Health in Tech Second Quarter of 2025 Earnings Conference Call.
Health In Tech, Inc. (HIT) Q1 2025 Earnings Call Transcript
Health In Tech, Inc. (NASDAQ:HIT ) Q1 2025 Earnings Conference Call April 14, 2025 5:00 PM ET Company Participants Lori Babcock - Chief of Staff Tim Johnson - Chief Executive Officer and Director Julia Qian - Chief Financial Officer and Director Conference Call Participants M Marin - Zacks Investment Research Allen Klee - Maxim Group [Transcript Provided by the Company to Seeking Alpha] Operator Good day, ladies and gentlemen. Thank you for standing by, and welcome to the Health in Tech First Quarter of 2025 Earnings Conference Call.
Health In Tech, Inc. (HIT) Q4 2024 Earnings Call Transcript
Health In Tech, Inc. (NASDAQ:HIT ) Q4 2024 Earnings Conference Call March 17, 2025 5:00 PM ET Company Participants Lori Babcock - Chief of Staff Tim Johnson - Chief Executive Officer and Director Julia Qian - Chief Financial Officer and Director Conference Call Participants Allen Klee - Maxim Group Operator Good day, ladies and gentlemen. Thank you for standing by, and welcome to the Health in Tech Fourth Quarter and Full Year of 2024 Earnings Conference Call.
